Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-25
DOI
10.3389/fendo.2021.790246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THE 2021 EUROPEAN GROUP ON GRAVES’ ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES’ ORBITOPATHY
- (2021) Luigi Bartalena et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study
- (2020) Jean-Baptiste Deltour et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- EFFICACY PROFILE AND SAFETY IMPLICATIONS OF VERY LOW DOSE RITUXIMAB IN PATIENTS WITH GRAVES’ ORBITOPATHY
- (2020) Guia Vannucchi et al. THYROID
- Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy
- (2018) Giovanna Rotondo Dottore et al. JAMA Ophthalmology
- B cells in Graves’ Orbitopathy: more than just a source of antibodies?
- (2018) Mario Salvi et al. EYE
- B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab
- (2017) Michelle Rosenzwajg et al. KIDNEY INTERNATIONAL
- MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy – lessons from randomized control trials
- (2016) Marius N Stan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
- (2016) Thomas Dörner et al. Nature Reviews Rheumatology
- Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis
- (2015) Markus Bredemeier et al. CLINICAL RHEUMATOLOGY
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
- (2015) Mario Salvi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves’ orbitopathy: A five-year follow-up study
- (2014) Annamaria Erdei et al. AUTOIMMUNITY
- The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy
- (2013) Anna L. Mitchell et al. CLINICAL ENDOCRINOLOGY
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Small Dose of Rituximab for Graves Orbitopathy: New Insights Into the Mechanism of Action
- (2012) Mario Salvi ARCHIVES OF OPHTHALMOLOGY
- Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
- (2012) L. Bartalena et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rundle and His Curve
- (2011) George B. Bartley ARCHIVES OF OPHTHALMOLOGY
- Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions
- (2010) G. Vannucchi et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunotoxicity of monoclonal antibodies
- (2010) Jacques Descotes mAbs
- Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy
- (2009) Dinesh Khanna et al. OPHTHALMOLOGY
- Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies
- (2008) Daniel El Fassi et al. CLINICAL IMMUNOLOGY
- Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease
- (2008) D. E. Fassi et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search